Ghana has made tremendous progress in the fight against malaria by rolling out proven malaria control measures, including long-lasting insecticide treated mosquito nets, indoor residual spraying, proper diagnosis, and effective chemoprevention with antimalarial medicines. Today, a malaria vaccine—known as RTS,S or Mosquirix—offers an additional way to protect young children from malaria. Ghana is one of three African countries (alongside Kenya and Malawi) that is carrying out the Malaria Vaccine Implementation Programme (MVIP) with support from the World Health Organization (WHO) and in collaboration with partners, including PATH, a nonprofit organization, and GSK, the vaccine manufacturer.